Novo Nordisk A/S Analysis
| Analyst Ratings |
|
Average Target Price
|
132.57
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
1.01
|
0.00
|
-1.01
|
-100.00%
|
|
2022-12-31
|
0.82
|
0.00
|
-0.82
|
-100.00%
|
|
2022-09-30
|
6.30
|
6.34
|
0.04
|
0.63%
|
|
2022-06-30
|
5.61
|
5.86
|
0.25
|
4.46%
|
|
2022-03-31
|
5.80
|
6.22
|
0.42
|
7.24%
|
|
2021-12-31
|
4.71
|
4.76
|
0.05
|
1.06%
|
|
2021-09-30
|
5.00
|
5.27
|
0.27
|
5.40%
|
|
2021-06-30
|
4.75
|
5.26
|
0.51
|
10.74%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
18.42
|
|
2021-12-31
|
20.74
|
|
2020-12-31
|
17.91
|
|
2019-12-31
|
16.42
|
|
2018-12-31
|
5.51
|
|
2017-12-31
|
2.33
|
|
2016-12-31
|
2.23
|
|
2015-12-31
|
2.02
|
|
2014-12-31
|
1.80
|
|
2013-12-31
|
1.66
|
|
2012-12-31
|
1.33
|
|
2011-12-31
|
1.12
|
|
2010-12-31
|
0.87
|
|
2009-12-31
|
0.66
|
|
2008-12-31
|
0.80
|
|
2005-12-31
|
0.06
|
|
2004-12-31
|
0.07
|
|
2002-12-31
|
0.15
|
|
2001-12-31
|
0.03
|
|
1994-12-31
|
0.05
|